The global Hib Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hib Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hib Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hib Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hib Vaccine players cover Bharat Biotech, Glaxosmithkline, Kangtai Bio, Lanzhou Institute, Olin Bio, Sanofi Pasteur, Watson Bio and Zhifei Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Hib vaccine is a vaccine to prevent invasive diseases caused by Hib, such as meningitis, pneumonia, epiglottitis, sepsis, cellulitis, pericarditis, myelitis, etc.
LPI (LP Information)' newest research report, the “Hib Vaccine Industry Forecast” looks at past sales and reviews total world Hib Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Hib Vaccine sales for 2023 through 2029. With Hib Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hib Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Hib Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hib Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hib Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hib Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hib Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Hib Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Hib Vaccine
Multiple Seedlings
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bharat Biotech
Glaxosmithkline
Kangtai Bio
Lanzhou Institute
Olin Bio
Sanofi Pasteur
Watson Bio
Zhifei Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hib Vaccine market?
What factors are driving Hib Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hib Vaccine market opportunities vary by end market size?
How does Hib Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Hib Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Hib Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Hib Vaccine by Country/Region, 2018, 2022 & 2029 2.2 Hib Vaccine Segment by Type 2.2.1 Hib Vaccine 2.2.2 Multiple Seedlings 2.3 Hib Vaccine Sales by Type 2.3.1 Global Hib Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global Hib Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global Hib Vaccine Sale Price by Type (2018-2023) 2.4 Hib Vaccine Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.5 Hib Vaccine Sales by Application 2.5.1 Global Hib Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global Hib Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global Hib Vaccine Sale Price by Application (2018-2023) 3 Global Hib Vaccine by Company 3.1 Global Hib Vaccine Breakdown Data by Company 3.1.1 Global Hib Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global Hib Vaccine Sales Market Share by Company (2018-2023) 3.2 Global Hib Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global Hib Vaccine Revenue by Company (2018-2023) 3.2.2 Global Hib Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global Hib Vaccine Sale Price by Company 3.4 Key Manufacturers Hib Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Hib Vaccine Product Location Distribution 3.4.2 Players Hib Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Hib Vaccine by Geographic Region 4.1 World Historic Hib Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global Hib Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Hib Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Hib Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global Hib Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global Hib Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas Hib Vaccine Sales Growth 4.4 APAC Hib Vaccine Sales Growth 4.5 Europe Hib Vaccine Sales Growth 4.6 Middle East & Africa Hib Vaccine Sales Growth 5 Americas 5.1 Americas Hib Vaccine Sales by Country 5.1.1 Americas Hib Vaccine Sales by Country (2018-2023) 5.1.2 Americas Hib Vaccine Revenue by Country (2018-2023) 5.2 Americas Hib Vaccine Sales by Type 5.3 Americas Hib Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Hib Vaccine Sales by Region 6.1.1 APAC Hib Vaccine Sales by Region (2018-2023) 6.1.2 APAC Hib Vaccine Revenue by Region (2018-2023) 6.2 APAC Hib Vaccine Sales by Type 6.3 APAC Hib Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Hib Vaccine by Country 7.1.1 Europe Hib Vaccine Sales by Country (2018-2023) 7.1.2 Europe Hib Vaccine Revenue by Country (2018-2023) 7.2 Europe Hib Vaccine Sales by Type 7.3 Europe Hib Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Hib Vaccine by Country 8.1.1 Middle East & Africa Hib Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa Hib Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa Hib Vaccine Sales by Type 8.3 Middle East & Africa Hib Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Hib Vaccine 10.3 Manufacturing Process Analysis of Hib Vaccine 10.4 Industry Chain Structure of Hib Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Hib Vaccine Distributors 11.3 Hib Vaccine Customer 12 World Forecast Review for Hib Vaccine by Geographic Region 12.1 Global Hib Vaccine Market Size Forecast by Region 12.1.1 Global Hib Vaccine Forecast by Region (2024-2029) 12.1.2 Global Hib Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Hib Vaccine Forecast by Type 12.7 Global Hib Vaccine Forecast by Application 13 Key Players Analysis 13.1 Bharat Biotech 13.1.1 Bharat Biotech Company Information 13.1.2 Bharat Biotech Hib Vaccine Product Portfolios and Specifications 13.1.3 Bharat Biotech Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Bharat Biotech Main Business Overview 13.1.5 Bharat Biotech Latest Developments 13.2 Glaxosmithkline 13.2.1 Glaxosmithkline Company Information 13.2.2 Glaxosmithkline Hib Vaccine Product Portfolios and Specifications 13.2.3 Glaxosmithkline Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Glaxosmithkline Main Business Overview 13.2.5 Glaxosmithkline Latest Developments 13.3 Kangtai Bio 13.3.1 Kangtai Bio Company Information 13.3.2 Kangtai Bio Hib Vaccine Product Portfolios and Specifications 13.3.3 Kangtai Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Kangtai Bio Main Business Overview 13.3.5 Kangtai Bio Latest Developments 13.4 Lanzhou Institute 13.4.1 Lanzhou Institute Company Information 13.4.2 Lanzhou Institute Hib Vaccine Product Portfolios and Specifications 13.4.3 Lanzhou Institute Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Lanzhou Institute Main Business Overview 13.4.5 Lanzhou Institute Latest Developments 13.5 Olin Bio 13.5.1 Olin Bio Company Information 13.5.2 Olin Bio Hib Vaccine Product Portfolios and Specifications 13.5.3 Olin Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Olin Bio Main Business Overview 13.5.5 Olin Bio Latest Developments 13.6 Sanofi Pasteur 13.6.1 Sanofi Pasteur Company Information 13.6.2 Sanofi Pasteur Hib Vaccine Product Portfolios and Specifications 13.6.3 Sanofi Pasteur Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Sanofi Pasteur Main Business Overview 13.6.5 Sanofi Pasteur Latest Developments 13.7 Watson Bio 13.7.1 Watson Bio Company Information 13.7.2 Watson Bio Hib Vaccine Product Portfolios and Specifications 13.7.3 Watson Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Watson Bio Main Business Overview 13.7.5 Watson Bio Latest Developments 13.8 Zhifei Bio 13.8.1 Zhifei Bio Company Information 13.8.2 Zhifei Bio Hib Vaccine Product Portfolios and Specifications 13.8.3 Zhifei Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Zhifei Bio Main Business Overview 13.8.5 Zhifei Bio Latest Developments 14 Research Findings and Conclusion